2025-01-10 – Press Releases – www.prnewswire.com
SHANGHAI, Jan. 10, 2025 /PRNewswire/ — JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, announced that the Center for Drug Evaluation (CDE) of the National Medical…